NLM Digital Collections

Search

Start Over Subjects Pharmacies ✖Remove constraint Subjects: Pharmacies Subjects United States ✖Remove constraint Subjects: United States

1. Drug supply chain security: dispensers received most tracing information

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, March 2018
Subject(s):
Pharmaceutical Preparations -- supply & distribution
Prescription Drug Diversion
Drug Industry
Information Dissemination
Pharmacies
Security Measures
Humans
United States
United States. Department of Health and Human Services.

3. Expanding access to naloxone: a review of distribution strategies

Author(s):
Weiner, Janet, author
Murphy, Sean , author
Behrends, Czarina, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2019
Subject(s):
Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Services Accessibility
Naloxone -- supply & distribution
Naloxone -- therapeutic use
Opioid-Related Disorders -- drug therapy
Community Health Services
Emergency Responders
Nonprescription Drugs
Opioid-Related Disorders -- epidemiology
Pharmacies
Humans
United States

4. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

5. Temporary policy on repackaging or combining propofol drug products during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Pharmaceutical Quality and Office of Compliance, April 2020
Subject(s):
Drug Packaging -- methods
Propofol -- supply & distribution
COVID-19
Drug Labeling
Pharmacies
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

6. Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised)

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Compliance May 21, 2020
Subject(s):
Drug Compounding -- methods
Hospitalization
Outsourced Services
Pharmacies
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

7. Few patients received high amounts of opioids from IHS-run pharmacies

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Analgesics, Opioid -- supply & distribution
Government Regulation
Pharmacies
Prescription Drug Monitoring Programs -- organization & administration
United States
United States. Department of Health and Human Services
United States. Indian Health Service